- Home
- LIN vs ABT Comparison
LIN vs ABT Comparison
Compare LIN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIN
- ABT
- Stock Information
- Founded
- LIN 1879
- ABT 1888
- Country
- LIN United Kingdom
- ABT United States
- Employees
- LIN N/A
- ABT N/A
- Industry
- LIN Major Chemicals
- ABT Medical/Dental Instruments
- Sector
- LIN Industrials
- ABT Health Care
- Exchange
- LIN Nasdaq
- ABT Nasdaq
- Market Cap
- LIN 218.9B
- ABT 204.9B
- IPO Year
- LIN N/A
- ABT N/A
- Fundamental
- Price
- LIN $424.31
- ABT $114.21
- Analyst Decision
- LIN Buy
- ABT Buy
- Analyst Count
- LIN 13
- ABT 15
- Target Price
- LIN $491.90
- ABT $129.80
- AVG Volume (30 Days)
- LIN 2.4M
- ABT 4.7M
- Earning Date
- LIN 02-04-2025
- ABT 01-22-2025
- Dividend Yield
- LIN 1.31%
- ABT 1.93%
- EPS Growth
- LIN 8.95
- ABT 12.04
- EPS
- LIN 13.18
- ABT 3.29
- Revenue
- LIN $33,025,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- LIN $2.14
- ABT $5.73
- Revenue Next Year
- LIN $5.20
- ABT $7.17
- P/E Ratio
- LIN $32.20
- ABT $34.72
- Revenue Growth
- LIN 1.77
- ABT 3.15
- 52 Week Low
- LIN $396.07
- ABT $99.71
- 52 Week High
- LIN $487.49
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- LIN 29.62
- ABT 46.60
- Support Level
- LIN $437.25
- ABT $111.28
- Resistance Level
- LIN $461.90
- ABT $114.15
- Average True Range (ATR)
- LIN 6.89
- ABT 1.77
- MACD
- LIN -2.30
- ABT -0.28
- Stochastic Oscillator
- LIN 13.84
- ABT 47.56
About LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2023.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.